-
Association Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal Outcomes. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-03-14 Anabel Starosta, Lisbet Lundsberg, Jennifer Culhane, Caitlin Partridge, Olga Grechukhina, Moeun Son
To evaluate the association between intrapartum nitrous oxide use and adverse short-term neonatal outcomes.
-
A Contemporary View of Menopausal Hormone Therapy. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-03-14 Barbara Levy, James A Simon
Enthusiasm for the use of hormones to ameliorate symptoms of perimenopause and menopause has waxed and waned over the years. Both treatment for symptoms and training of women's health care practitioners in the management of menopause have sharply declined since publication of the Women's Health Initiative initial results in 2002. Findings from that trial, which treated a population of older, asymptomatic
-
Child Protection System Removal and Short-Interval Births Among Individuals With Prenatal Substance Use. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-03-14 Julia Reddy, Davida Schiff, Mishka Terplan, Hendree Jones, Emily Putnam-Hornstein
Child protection systems often intervene after substance-exposed births but are not designed to address the postpartum needs of the delivering parent. In this retrospective cohort study, we aimed to estimate the association between early child protection system removal and high-risk subsequent birth trajectories among a cohort of mothers with substance-exposed births in California. Of 6,893 births
-
Pregnancy Outcomes After Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas Compared With Myomectomy. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-03-01 Antoinette Allen, Michael Schembri, Ram Parvataneni, L Elaine Waetjen, Shira Varon, Naghmeh Salamat-Saberi, Shawn Tassone, Nicole Williams, Kimberly A Kho, Vanessa L Jacoby
To compare pregnancy outcomes after laparoscopic radiofrequency ablation and myomectomy.
-
An Update on Prenatal Diethylstilbestrol Exposure and High-Grade Squamous Intraepithelial Lesions of the Lower Genital Tract. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-29 Rebecca Troisi, Kimberly Bertrand, Elizabeth E Hatch, William C Strohsnitter, Kjersti Aagaard, Stanley J Robboy, Gretchen Gierach, Linda Titus
Women with prenatal diethylstilbestrol exposure are excluded from less frequent cervical cancer screening because of their increased neoplasia risk. We report the results of a prospective follow-up study of prenatal diethylstilbestrol exposure and lower genital tract high-grade (grade 2 or higher) squamous intraepithelial lesions (HSIL). The age-adjusted risk of HSIL among diethylstilbestrol-exposed
-
Association of Adverse Childhood Experiences and Resilience With Depression and Anxiety During Pregnancy. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-29 Carey R Watson, Abigail Eaton, Cynthia I Campbell, Stacey E Alexeeff, Lyndsay A Avalos, Kathryn K Ridout, Kelly C Young-Wolff
This was a retrospective cohort study of pregnant individuals in the Kaiser Permanente Northern California system who were screened for adverse childhood experiences and resilience as part of standard prenatal care at about 16 weeks of gestation. Overall, 14,625 pregnancies were included; 17.0% had newly identified depression; 9.8% had newly identified depression symptoms; and 8.9% had newly identified
-
Universal Fetal Echocardiography for Pregestational Diabetes Mellitus: A Cost-Effectiveness Analysis. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-29 Leah M Savitsky, Caitlin Hamilton, Mary Sterrett, Kelsey Olerich, Kimberly Ma, Catherine M Albright
To evaluate the cost effectiveness of universal fetal echocardiogram for patients with pregestational diabetes mellitus by first-trimester hemoglobin A1c (Hb A1c) level.
-
Applying Tension to the Transcervical Foley Balloon and Delivery Times in Term Nulliparous Women Undergoing Induction of Labor: A Randomized Controlled Trial. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-29 Meagan Benson, Lena Younes, Alisha Watson, George R Saade, Antonio F Saad
To investigate the effects of applying tension to a transcervical Foley balloon on delivery time in term nulliparous patients undergoing labor induction.
-
Timing of Coronavirus Disease 2019 (COVID-19) Vaccination and Effects on Menstrual Cycle Changes. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-27 Alison Edelman, Emily R Boniface, Victoria Male, Sharon Cameron, Eleonora Benhar, Leo Han, Kristen A Matteson, Agathe van Lamsweerde, Jack T Pearson, Blair G Darney
To assess whether menstrual cycle timing (follicular or luteal phase) of coronavirus disease 2019 (COVID-19) vaccine administration is associated with cycle length changes.
-
Treating Mild Chronic Hypertension During Pregnancy: A Cost-Effectiveness Analysis. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-22 Uma Doshi, Sarina Chaiken, Alyssa Hersh, Karen J Gibbins, Aaron B Caughey
To assess the cost effectiveness of targeting a blood pressure of less than 140/90 mm Hg compared with 160/105 mm Hg.
-
Hospital Discharge Codes and Overestimating Severe Maternal Morbidity During Delivery Hospitalization. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-22 Johanna Quist-Nelson, Marie-Louise Meng, Divya Mallampati, Jerome J Federspiel, Lauren M Kucirka, Matthew Fuller, M Kathryn Menard
Our objective was to identify birth hospitalization severe maternal morbidity (SMM) diagnoses that were also coded during prior encounters and, thus, potentially falsely carried forward as de novo SMM events. This retrospective cohort study included pregnant patients with births between 2016 and 2020. We applied the SMM algorithm to the birth hospitalization and encounters occurring prepregnancy, antepartum
-
A Treatment Algorithm for High-Tone Pelvic Floor Dysfunction. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-22 Michele Torosis, Erin Carey, Kristin Christensen, Melissa R Kaufman, Kimberly Kenton, Rhonda Kotarinos, H Henry Lai, Una Lee, Jerry L Lowder, Melanie Meister, Theresa Spitznagle, Kelly Wright, A Lenore Ackerman
To develop evidence- and consensus-based clinical practice guidelines for management of high-tone pelvic floor dysfunction (HTPFD). HTPFD is a neuromuscular disorder of the pelvic floor characterized by non-relaxing pelvic floor muscles, resulting in lower urinary tract and defecatory symptoms, sexual dysfunction, and pelvic pain. Despite affecting 80% of women with chronic pelvic pain, there are no
-
Uterine Sacculation With Entrapped Placenta After Delivery. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-13 Michael T Solotke, Glenn Boyles, Kara Rood, Emily Hinchcliff, Jeanne M Horowitz, Lynn M Yee
Uterine sacculation refers to a temporary pouch or sac within the uterus that may contain the placenta or fetal parts and that may be diagnosed antepartum or after delivery. There is very limited published information about this rare condition and its management.
-
Angiogenic Biomarkers in Preeclampsia. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-13 Richard M Burwick, M Hellen Rodriguez
Preeclampsia contributes disproportionately to maternal and neonatal morbidity and mortality throughout the world. A critical driver of preeclampsia is angiogenic imbalance, which is often present weeks to months before overt disease. Two placenta-derived angiogenic biomarkers, soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF), have proved useful as diagnostic and prognostic
-
A Comparison of Newer and Traditional Approaches to Diagnosing Vaginal Infections. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-13 Anna Powell, Oluwatosin Goje, Paul Nyirjesy
Molecular diagnostic testing (eg, polymerase chain reaction [PCR]-based vaginitis testing) is widely used in clinical practice, although vaginitis experts have reservations about its use for vaginitis diagnosis. As with any new technology, cost to the health system is a large concern. Although clinical evaluation of signs and symptoms along with wet mount microscopy is traditionally used for vaginitis
-
Effects of Obesity on Urogynecologic Prolapse Surgery Outcomes: A Systematic Review and Meta-analysis. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-08 Nancy E Ringel, Stacy M Lenger, Rachel High, Alexandriah Alas, Sara Houlihan, Olivia H Chang, Jon Pennycuff, Ruchira Singh, Amanda White, Lioudmila Lipitskaia, Sadikah Behbehani, David Sheyn, Bela Kudish, Mikio Nihira, Ambereen Sleemi, Cara Grimes, Ankita Gupta, Ethan M Balk, Danielle D Antosh
To systematically review the literature on outcomes of pelvic organ prolapse (POP) surgery in patients from various body mass index (BMI) categories to determine the association between obesity and surgical outcomes.
-
Endometrial Cancer in a Transgender Man with Prolonged Exogenous Testosterone Use. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-08 Stephanie Gill, Michelle Anderson, Joannie Neveu
Hormone therapy (HT) in transgender males requires monitoring. For amenorrheic transmasculine individuals on HT, episodes of abnormal vaginal bleeding should be assessed promptly.
-
Understanding New Recommendations for Respiratory Syncytial Virus Prevention in Pregnancy. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-08 Rebecca Horgan, Brenna L Hughes, Jerri Waller, Yara Hage Diab, George Saade
Respiratory syncytial virus (RSV) is a significant cause of infant morbidity and mortality worldwide with peak hospitalization rates for RSV-mediated illnesses between 2 and 3 months of life. Until very recently, prevention strategies for RSV involved primarily passive immunization of neonates at high risk with monoclonal antibodies and promotion of breastfeeding. The Centers for Disease Control and
-
Neonatal Birth Weight With Daily Compared With Every-Other-Day Glucose Monitoring in Gestational Diabetes Mellitus: A Randomized Controlled Trial. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-08 Kristina Martimucci Feldman, Arielle Coughlin, Jasmin Feliciano, Guillaume Stoffels, Kelly Z Wang, Tirtza Spiegel Strauss, Olivia Grubman, Zainab Al-Ibraheemi, David Cole, Graham Ashmead, Farrah Hussain, Sophia Scarpelli Shchur, Deborah Lee, Lois Brustman
To assess whether universal use of every-other-day glucose monitoring in patients with gestational diabetes mellitus (GDM) resulted in similar birth weights and medication use and was preferred by the patient compared with traditional daily glucose monitoring.
-
Late Preterm Antenatal Steroids for Reduction of Neonatal Respiratory Complications: A Randomized Controlled Trial. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-08 Hilda Yenuberi, Benjamin Ross, Richa Sasmita Tirkey, Santosh Joseph Benjamin, Swati Rathore, Reka Karuppusami, Aadarsh Lal, Niranjan Thomas, Jiji Elizabeth Mathew
To evaluate the efficacy of antenatal corticosteroids in reducing neonatal respiratory complications when administered to those at risk of preterm delivery between 34 and 36 6/7 weeks of gestation.
-
Structural Racism and Use of Labor Neuraxial Analgesia Among Non-Hispanic Black Birthing People. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-01 Jean Guglielminotti, Allison Lee, Ruth Landau, Goleen Samari, Guohua Li
To assess the association between structural racism and labor neuraxial analgesia use.
-
Enabling Technologies for Gynecologic Vaginal Surgery: A Systematic Review. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-01 Sunil Balgobin, Ethan M Balk, Anne E Porter, Meenal Misal, Tamara Grisales, Kate V Meriwether, Peter C Jeppson, Paula J Doyle, Sarit O Aschkenazi, Jeannine M Miranne, Deslyn T Hobson, David L Howard, Saifuddin Mama, Ankita Gupta, Danielle D Antosh
To systematically review the literature to evaluate clinical and surgical outcomes for technologies that facilitate vaginal surgical procedures.
-
Association Between Neighborhood Deprivation in Early Pregnancy and Gestational Diabetes Mellitus. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-01 Emily F Liu, Assiamira Ferrara, Sneha B Sridhar, Mara B Greenberg, Monique M Hedderson
To evaluate whether having a pregnancy in a deprived neighborhood was associated with an increased risk of gestational diabetes mellitus (GDM) compared with having a pregnancy in the least-deprived neighborhoods.
-
Inpatient Management of Hyperemesis Gravidarum. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-01 Shannon M Clark, Xue Zhang, Daphne Arena Goncharov
Hyperemesis gravidarum has a reported incidence of approximately 0.3-3% of pregnancies. Without treatment, refractory hyperemesis gravidarum can result in dehydration, electrolyte deficiencies, and severe nutritional deficiencies, resulting in significant maternal morbidity. The overall goals of inpatient management of refractory hyperemesis gravidarum are the resumption of oral intake to an adequate
-
Addressing Privacy Concerns Surrounding Oocyte Donation in the United States: Gone With Anonymity. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-02-01 Shelun Tsai, Jennifer L Eaton
Oocyte donation has greatly expanded in the past several decades since the first procedure was performed in 1983. According to the Centers for Disease Control, the number of cycles using donor oocytes increased from 18,011 cycles in 2010 to 27,131 cycles in 2019. Oocyte donation has become an important reproductive option for women with diminished ovarian reserve, recurrent failed in vitro fertilization
-
Outcomes After Induction of Labor Compared With Dilation and Evacuation for the Management of Rupture of Membranes in the Second Trimester. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-23 Elizabeth A Hoffman, Jason Kaufman, Nathanael C Koelper, Sarita Sonalkar, Andrea H Roe
Previable and periviable rupture of membranes is associated with significant morbidity for the pregnant patient. For those who have a choice of options and undergo active management, it is not known how the risks of induction of labor compare with those for dilation and evacuation (D&E). We performed a retrospective cohort study of patients with rupture of membranes between 14 0/7 and 23 6/7 weeks
-
Neurodevelopment of Children Whose Mothers Were Randomized to Low-Dose Aspirin During Pregnancy. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-23 Matthew K Hoffman, Shivaprasad Goudar, Sangappa Dhaded, Lester Figueroa, Manolo Mazariegos, Nancy F Krebs, Jamie Westcott, Shiyam Sunder Tikmani, Fatima Karim, Sarah Saleem, Robert L Goldenberg, Adrien Lokangaka, Antoinette Tshefu, Melissa Bauserman, Archana Patel, Prabir Das, Patricia Hibberd, Elwyn Chomba, Musaku Mwenchanya, Waldemar A Carlo, Marissa Trotta, Alexis Williams, Janet Moore, Tracy Nolen
Because low-dose aspirin is now commonly prescribed in pregnancy, we sought to assess the association between early antenatal exposure and child neurodevelopment.
-
Permanent Contraception: Ethical Issues and Considerations: ACOG Committee Statement No. 8. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-1-18
Permanent contraception is the most used method of contraception among women aged 15-49 years and is one of the most straightforward surgical procedures an obstetrician-gynecologist can perform. At the same time, this therapeutic option is enormously complex when considered from a historical, sociological, or ethical perspective. This Committee Statement reviews ethical issues related to permanent
-
The Evaluation of Payment for Obstetric and Gynecology Services: From ACOG. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-1-18
To perform an environmental scan of the current status of reimbursement for obstetric and gynecology services and identify problematic issues and opportunities for change. The areas that were evaluated include the American Medical Association (AMA) relative value unit assignment process, payer rates (where available), and trends in employment and salary determination for obstetrician-gynecologists
-
Immunosuppressant Medications in Pregnancy. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-16 Antonio F Saad, Luis D Pacheco, George R Saade
Pregnant patients are often on immunosuppressant medications, most commonly to manage transplantation or autoimmune disorders. Most immunosuppressant agents, including tacrolimus, corticosteroids, azathioprine, and calcineurin inhibitors, are safe during pregnancy and lactation. However, mycophenolic acid is associated with higher risks of birth defects and should be avoided in pregnancy. Tacrolimus
-
Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms: A Meta-analysis. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-16 Krishna Nikhila Bonga, Archana Mishra, Rituparna Maiti, Biswa Mohan Padhy, Bikash Ranjan Meher, Anand Srinivasan
To evaluate the efficacy and adverse events of fezolinetant for treating vasomotor symptoms (VMS) of menopause.
-
Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-16 Anja Bauerfeind, Sophia von Stockum, Tanja Boehnke, Klaas Heinemann
This pooled analysis compared the risk of venous thromboembolism (VTE) associated with combined oral contraceptives (COCs) containing estradiol (E2) valerate-dienogest with those containing ethinyl E2-levonorgestrel. Data were retrieved from two large, prospective, observational cohort studies. Propensity score subclassification was applied to balance baseline parameters between the COC user cohorts
-
Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-16 Sreevalli Atluru, Alyssa K Bruehlman, Porcia Vaughn, Charles W Schauberger, Marcela C Smid
Although naltrexone is an evidence-based medication for opioid use disorder (MOUD), few data are available with use in pregnancy. Our objective was to assess outcomes of pregnant individuals with opioid use disorder (OUD) taking naltrexone compared with those taking methadone or buprenorphine.
-
Longitudinal Reoperation Risk After Apical Prolapse Procedures in Women Aged 65 Years and Older. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-16 Alexander A Berger, Carol E Bretschneider, W Thomas Gregory, Vivian Sung
To describe longitudinal reoperation risk among older women undergoing surgery for apical pelvic organ prolapse (POP) and to compare risk of reoperation for prolapse and complications among different surgical approaches.
-
Activity Restrictions After Gynecologic Surgery. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-11 Margaret G Mueller, Kimberly Kenton
Gynecologic surgeons have traditionally restricted the physical activity of postoperative patients. Minimally invasive surgery and enhanced recovery after surgery programs have contributed to decreased hospital stays and more expeditious recovery. In this narrative review, we review the current state of postoperative activity restrictions in gynecology and other specialties, the purported risks and
-
Urethral Bulking With Polyacrylamide Hydrogel Compared With Other Treatments for Stress Urinary Incontinence: A Cost-Effectiveness Analysis. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-11 Olivia H Chang, Jonathan P Shepherd, Lauren A Cadish, Shannon L Wallace, Brad St Martin, Eric R Sokol
Our objective was to perform a cost-effectiveness analysis comparing polyacrylamide hydrogel urethral bulking with other surgical and nonsurgical treatments for stress urinary incontinence (SUI). We created a cost-effectiveness analysis using TreeAge Pro, modeling eight SUI treatments. Treatment with midurethral sling (MUS) had the highest effectiveness (1.86 quality-adjusted life-years [QALYs]), followed
-
Geographic Access to Early Pregnancy Loss Management. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-11 Jamie W Krashin, Patricia Black, Eric Brannen, Charlotte C Gard, Yan Lin, Margaret Greenwood-Ericksen, Victoria Y Trujillo, Gillian Burkhardt, Courtney A Schreiber
Early pregnancy loss (EPL) is common, but patients face barriers to the most effective medication (mifepristone followed by misoprostol) and procedural (uterine aspiration) management options. This cross-sectional geospatial analysis evaluated access in New Mexico to mifepristone and misoprostol and uterine aspiration in emergency departments (comprehensive) and to uterine aspiration anywhere in a
-
Sexual Health in Women Affected by Gynecologic or Breast Cancer. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-11 Katina Robison, Amita Kulkarni, Don S Dizon
Sexual health problems are prevalent among women affected by gynecologic or breast cancer. It is important to understand the effects cancer treatment can have on sexual health and to have the tools necessary to identify and treat sexual health problems. This Clinical Expert Series discusses practical methods for routinely screening for sexual dysfunction and reviews sexual health treatment options
-
Association Between Length of Maternity Leave and Breastfeeding Duration in the United States: A Systematic Review. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-11 Lorena Wicklund, Allison Epstein, Heidi Szugye, Mary Schleicher, Suet Kam Lam
To perform a systematic review to assess the association between the length of maternity leave and breastfeeding duration in the United States.
-
Effect of Uterine Leiomyomas on Noninvasive Prenatal Testing Parameters in the First Trimester. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-11 Teodora R Kolarova, Ali Alderson, Hayley MacKinnon, Leah Chen, Jillian G Buchan, Christina Lockwood, Raj Shree
Uterine leiomyomas may affect the performance of cell-free DNA (cfDNA)-based noninvasive prenatal testing (NIPT). We conducted a retrospective cohort study of pregnant individuals with and without leiomyomas undergoing first-trimester cfDNA-based NIPT. Characteristics of NIPT in patients with leiomyomas (n=122) were compared with those in patients without leiomyomas (n=937). Mean fetal fraction was
-
Evaluation of Recurrent Pregnancy Loss. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-04 Viviana de Assis, Claudio Schenone Giugni, Stephanie T Ros
Recurrent pregnancy loss (RPL) affects approximately 5% of couples. Although RPL definitions vary across professional societies, an evaluation after a second clinically recognized first-trimester pregnancy loss is recommended. Good quality evidence links parental chromosomal rearrangements, uterine anomalies, and antiphospholipid syndrome (APS) to RPL. In contrast, the relationship between RPL and
-
Breastfeeding Initiation, Duration, and Associated Factors Among People With Hepatitis C Virus Infection. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-04 Jennifer L Grasch, Jessica A de Voest, George R Saade, Brenna L Hughes, Uma M Reddy, Maged M Costantine, Edward K Chien, Alan T N Tita, John M Thorp, Torri D Metz, Ronald J Wapner, Vishakha Sabharwal, Hyagriv N Simhan, Geeta K Swamy, Kent D Heyborne, Baha M Sibai, William A Grobman, Yasser Y El-Sayed, Brian M Casey, Samuel Parry
To characterize breastfeeding behaviors and identify factors associated with breastfeeding initiation among people with hepatitis C virus (HCV) infection.
-
Equitable Care for Patients With Disabilities: Considerations for the Gynecologic Health Care Professional. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-04 Julie P Barbera, Bridget Cichon, Nethra Ankam, Beth I Schwartz
All patients deserve high-quality health care. Patients with disabilities have historically experienced discrimination in health care and subsequently detrimental health outcomes. Health care professionals often lack confidence and preparedness in treating patients with disabilities effectively. Barriers such as communication difficulties, biased assumptions, and inadequate equipment hinder comprehensive
-
Validity of Birth Certificate Data Compared With Hospital Discharge Data in Reporting Maternal Morbidity and Disparities. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-04 Alison Gemmill, Molly Passarella, Ciaran S Phibbs, Elliott K Main, Scott A Lorch, Katy B Kozhimannil, Suzan L Carmichael, Stephanie A Leonard
A growing number of studies are using birth certificate data, despite data-quality concerns, to study maternal morbidity and associated disparities. We examined whether conclusions about the incidence of maternal morbidity, including Black-White disparities, differ between birth certificate data and hospitalization data. Using linked birth certificate and hospitalization data from California and Michigan
-
Early Ovarian Cancer Detection in the Age of Fallopian Tube Precursors: A Systematic Review. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-01-04 Ashley Greenwood, Elizabeth R Woodruff, Cam Nguyen, Christi Piper, Aaron Clauset, Lindsay W Brubaker, Kian Behbakht, Benjamin G Bitler
To determine biomarkers other than CA 125 that could be used in identifying early-stage ovarian cancer.
-
Estimated National Cost of Pelvic Organ Prolapse Surgery in the United States. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-21 Brad St Martin, Melissa A Markowitz, Evan R Myers, Lisbet S Lundsberg, Nancy Ringel
To estimate the national cost of pelvic organ prolapse (POP) surgery in the United States.
-
Maternal Mortality: A National Institutes of Health Pathways to Prevention Panel Report. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-21 Karina W Davidson, Mary Beth Terry, Paula Braveman, Pamela J Reis, Stefan Timmermans, John W Epling
The National Institutes of Health's (NIH) Pathways to Prevention panel on postpartum health provides a consensus statement on the evidence, research gaps, and future priorities to prevent maternal morbidity and mortality. The panel reviewed an NIH-commissioned evidence review and workshop that included epidemiologic studies, demonstration interventions, and other maternal morbidity and mortality research
-
An Evidence Map for Social and Structural Determinants for Maternal Morbidity and Mortality: A Systematic Review. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-21 Carrie Neerland, Jaime Slaughter-Acey, Kathryn Behrens, Amy M Claussen, Timothy Usset, Sameerah Bilal-Roby, Huda Bashir, Andrea Westby, Brittin Wagner, Donna McAlpine, Melanie Dixon, Mengli Xiao, Damaris Avila, Mary Butler
To identify the social-structural determinants of health risk factors associated with maternal morbidity and mortality in the United States during the prenatal and postpartum periods.
-
Fetoscopic Endoluminal Tracheal Occlusion for Severe, Left-Sided Congenital Diaphragmatic Hernia: The North American Fetal Therapy Network Fetoscopic Endoluminal Tracheal Occlusion Consortium Experience. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-21 Eric Bergh, Ahmet A Baschat, Magdalena Sanz Cortes, Holly L Hedrick, Greg Ryan, Foong-Yen Lim, Michael V Zaretsky, Mauro H Schenone, Timothy M Crombleholme, Rodrigo Ruano, Kristen A Gosnell, Anthony Johnson
To report the outcomes of fetoscopic endoluminal tracheal occlusion in a multicenter North American cohort of patients with isolated, left-sided congenital diaphragmatic hernia (CDH) and to compare neonatal mortality and morbidity in patients with severe left-sided congenital diaphragmatic hernia who underwent fetoscopic endoluminal tracheal occlusion with those expectantly managed.
-
First and Second Stage Labor Management: ACOG Clinical Practice Guideline No. 8. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-14
The purpose of this document is to define labor and labor arrest and provide recommendations for the management of dystocia in the first and second stage of labor and labor arrest.
-
Hospital Volume and Quality of Care for Emergency Gynecologic Care. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-13 Vanessa Kalinowska, Yongmei Huang, Alexander Buckley, Caryn M St Clair, Tarah Pua, Fady Khoury-Collado, June Y Hou, Dawn L Hershman, Jason D Wright
To evaluate the association between hospital volume and the quality of gynecologic emergency care for tubal ectopic pregnancies, ovarian torsion, and pelvic inflammatory disease (PID).
-
Performance Characteristics of Sepsis Screening Tools During Antepartum and Postpartum Admissions. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-12 Melissa E Bauer, Matt Fuller, Vesela Kovacheva, Rania Elkhateb, Kristen Azar, Morgan Caldwell, Vanna Chiem, Mindy Foster, Ronald Gibbs, Brenna L Hughes, Rebecca Johnson, Nobin Kottukapally, Melissa G Rosenstein, Magdalena Sanz Cortes, Laurence E Shields, Sylvia Sudat, Caitlin D Sutton, Paloma Toledo, Austin Traylor, Kurt Wharton, Elliott Main
To evaluate the performance characteristics of existing screening tools for the prediction of sepsis during antepartum and postpartum readmissions.
-
Performance Characteristics of Sepsis Screening Tools During Delivery Admissions. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-12 Elliott K Main, Matt Fuller, Vesela P Kovacheva, Rania Elkhateb, Kristen Azar, Morgan Caldwell, Vanna Chiem, Mindy Foster, Ronald Gibbs, Brenna L Hughes, Rebecca Johnson, Nobin Kottukapally, Magdalena Sanz Cortes, Melissa G Rosenstein, Laurence E Shields, Sylvia Sudat, Caitlin D Sutton, Paloma Toledo, Austin Traylor, Kurt Wharton, Melissa E Bauer
To evaluate the screening performance characteristics of existing tools for the diagnosis of sepsis during delivery admissions.
-
Abortion Trigger Laws Compared With the Emergency Medical Treatment and Labor Act. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-12 Steven B Cherry
In 2022, the Supreme Court decision in Dobbs v Jackson Women's Health Organization reneged the Constitutional right to an abortion. Many states now enforce laws that ban abortions. There are significant conflicts between state abortion laws and federal regulations that mandate proper assessment, treatment, and stabilization of patients who present for emergency care. This conflict places physicians
-
What U.S. Obstetricians Need to Know About Respiratory Syncytial Virus. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-08 Haben Debessai, Jefferson M Jones, Dana Meaney-Delman, Sonja A Rasmussen
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in neonates, infants, and children worldwide. The virus is estimated to infect 97% of this population in the United States by the age of 2 years, leading to hospitalization for severe lower respiratory tract disease in 2-3% of infants younger than age 6 months. Two preventive options, prenatal administration
-
Establishment of Noninvasive Prediction Models for the Diagnosis of Uterine Leiomyoma Subtypes. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-07 Tetsuro Tamehisa, Shun Sato, Takahiro Sakai, Ryo Maekawa, Masahiro Tanabe, Katsuyoshi Ito, Norihiro Sugino
To establish prediction models for the diagnosis of the subtypes of uterine leiomyomas by machine learning using magnetic resonance imaging (MRI) data.
-
Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-07 David D Rahn, Holly E Richter, Vivian W Sung, Linda S Hynan, Jessica E Pruszynski
To identify clinical and demographic characteristics associated with prolapse recurrence by 12 months after native tissue transvaginal repair.
-
Prolongation of the Menstrual Cycle After Receipt of the Primary Series and Booster Doses of mRNA Coronavirus Disease 2019 (COVID-19) Vaccination. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-07 Satoshi Hosoya, Aurelie Piedvache, Akari Nakamura, Risa Nasu, Maaya Hine, Shiori Itoi, Ryo Yokomizo, Akihiro Umezawa, Osamu Hiraike, Kaori Koga, Yutaka Osuga, Satoshi Narumi, Naho Morisaki
To quantitatively evaluate the effect of a booster vaccination dose against coronavirus disease 2019 (COVID-19) on menstrual cycle in a large-scale retrospective cohort study using a menstrual cycle tracking smartphone application (app).
-
Association Between Doula Use on a Digital Health Platform and Birth Outcomes. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-12-05 Smriti Karwa, Hannah Jahnke, Alison Brinson, Neel Shah, Constance Guille, Natalie Henrich
To examine the association between the use of virtual doula appointments on a comprehensive digital health platform and users' mode of birth and their birth experiences, among all platform users and Black platform users.
-
Repair of Vesicovaginal Fistulae: A Systematic Review. Obstet. Gynecol. (IF 7.2) Pub Date : 2023-11-30 Jennifer C Thompson, Gabriela E Halder, Peter C Jeppson, Alexandriah Alas, Sunil Balgobin, Alexis A Dieter, Sara Houlihan, Jeannine Miranne, Ambereen Sleemi, Ethan M Balk, Saifuddin Mama, Kate V Meriwether, Danielle D Antosh
To assess and compile the current level of evidence regarding successful surgical treatment of vesicovaginal fistulae and how these perioperative interventions affect anatomic, patient-centered, and adverse outcomes.